Citadel Advisors’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $936K | Buy |
207,642
+53,687
| +35% | +$242K | ﹤0.01% | 3380 |
|
2025
Q1 | $682K | Sell |
153,955
-67,959
| -31% | -$301K | ﹤0.01% | 3673 |
|
2024
Q4 | $1.74M | Sell |
221,914
-52,633
| -19% | -$412K | ﹤0.01% | 2744 |
|
2024
Q3 | $3.61M | Buy |
274,547
+12,803
| +5% | +$168K | ﹤0.01% | 2020 |
|
2024
Q2 | $3.16M | Buy |
261,744
+143,443
| +121% | +$1.73M | ﹤0.01% | 2032 |
|
2024
Q1 | $1.92M | Sell |
118,301
-19,199
| -14% | -$312K | ﹤0.01% | 2528 |
|
2023
Q4 | $938K | Sell |
137,500
-276,807
| -67% | -$1.89M | ﹤0.01% | 3095 |
|
2023
Q3 | $2.26M | Buy |
414,307
+382,794
| +1,215% | +$2.09M | ﹤0.01% | 2292 |
|
2023
Q2 | $214K | Sell |
31,513
-274,197
| -90% | -$1.86M | ﹤0.01% | 4395 |
|
2023
Q1 | $1.53M | Sell |
305,710
-654,711
| -68% | -$3.28M | ﹤0.01% | 2770 |
|
2022
Q4 | $4.69M | Buy |
960,421
+869,961
| +962% | +$4.25M | ﹤0.01% | 1842 |
|
2022
Q3 | $1.3M | Buy |
+90,460
| New | +$1.3M | ﹤0.01% | 3151 |
|
2022
Q2 | – | Sell |
-26,927
| Closed | -$320K | – | 7022 |
|
2022
Q1 | $320K | Sell |
26,927
-98,771
| -79% | -$1.17M | ﹤0.01% | 4884 |
|
2021
Q4 | $2.04M | Buy |
125,698
+21,183
| +20% | +$343K | ﹤0.01% | 3034 |
|
2021
Q3 | $2.98M | Sell |
104,515
-70,670
| -40% | -$2.02M | ﹤0.01% | 2560 |
|
2021
Q2 | $5.92M | Buy |
175,185
+83,790
| +92% | +$2.83M | ﹤0.01% | 1964 |
|
2021
Q1 | $2.76M | Sell |
91,395
-24,074
| -21% | -$728K | ﹤0.01% | 2813 |
|
2020
Q4 | $5.72M | Buy |
115,469
+106,301
| +1,159% | +$5.26M | ﹤0.01% | 1667 |
|
2020
Q3 | $352K | Sell |
9,168
-3,832
| -29% | -$147K | ﹤0.01% | 3735 |
|
2020
Q2 | $561K | Sell |
13,000
-24,913
| -66% | -$1.08M | ﹤0.01% | 3362 |
|
2020
Q1 | $990K | Sell |
37,913
-32,415
| -46% | -$846K | ﹤0.01% | 2876 |
|
2019
Q4 | $2.2M | Buy |
+70,328
| New | +$2.2M | ﹤0.01% | 2268 |
|